Sign In
Buy VERA
$31.58
-1.31 (-3.98%)
At Close: Aug 10, 2026
Vera Therapeutics to Present at Upcoming Investment Conferences in November 2021
04:15pm, Wednesday, 10'th Nov 2021
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative t
SOUTH SAN FRANCISCO, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing treatments for immunological disease
Vera Therapeutics Hosting Key Opinion Leader Webinar on IgA Nephropathy
07:30am, Thursday, 09'th Sep 2021
SOUTH SAN FRANCISCO, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing treatments for immunological diseas
Vera Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
07:30am, Monday, 16'th Aug 2021
SOUTH SAN FRANCISCO, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing treatments for immunological disease
Vera Therapeutics Appoints Sean Grant as Chief Financial Officer
07:30am, Wednesday, 14'th Jul 2021
Healthcare and financial services industry veteran brings nearly 15 years of multi-disciplinary financial experience and proven track record in strategic investments, equity capital markets, and partn
Vera Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
07:15am, Thursday, 24'th Jun 2021
Completed an initial public offering with net proceeds, including the exercise of the underwriters' option in full, of approximately $48.4 million in May 2021 - - - Expanded the management team to sup
Vera Therapeutics to Participate in the Jefferies Virtual Healthcare Conference
04:05pm, Thursday, 27'th May 2021
SOUTH SAN FRANCISCO, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative tr
U.S. IPO Weekly Recap: Postponements Abound In A Turbulent 5 IPO Week
11:00pm, Saturday, 15'th May 2021
The IPO market had a tumultuous week with five IPOs and three postponements. SPAC activity remained steady, with two blank check IPOs raising $430 million.
Gene Therapy Player Vera Therapeutics Prices IPO Well Below Range At $11/Share
03:40pm, Friday, 14'th May 2021
Vera Therapeutics Inc has priced its 4.35 million share IPO at $11 per share, well below its targeted range of $14 to $16, raising $47.58 million in gross proceeds. The biotech will start trading on
Vera Therapeutics Announces Pricing of Initial Public Offering
08:52pm, Thursday, 13'th May 2021
SOUTH SAN FRANCISCO, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a clinical-stage biotechnology company focused on developing and commercializing transformative trea
